Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
- PMID: 12077607
- DOI: 10.1038/nature00900
Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
Abstract
Parkinson's disease is a widespread condition caused by the loss of midbrain neurons that synthesize the neurotransmitter dopamine. Cells derived from the fetal midbrain can modify the course of the disease, but they are an inadequate source of dopamine-synthesizing neurons because their ability to generate these neurons is unstable. In contrast, embryonic stem (ES) cells proliferate extensively and can generate dopamine neurons. If ES cells are to become the basis for cell therapies, we must develop methods of enriching for the cell of interest and demonstrate that these cells show functions that will assist in treating the disease. Here we show that a highly enriched population of midbrain neural stem cells can be derived from mouse ES cells. The dopamine neurons generated by these stem cells show electrophysiological and behavioural properties expected of neurons from the midbrain. Our results encourage the use of ES cells in cell-replacement therapy for Parkinson's disease.
Comment in
-
A human stem cell project?Nature. 2002 Jul 4;418(6893):1. doi: 10.1038/418001a. Nature. 2002. PMID: 12097865 No abstract available.
-
Stem-cell competition.Nature. 2002 Jul 4;418(6893):25-7. doi: 10.1038/418025a. Nature. 2002. PMID: 12097889 No abstract available.
Similar articles
-
Stem-cell competition.Nature. 2002 Jul 4;418(6893):25-7. doi: 10.1038/418025a. Nature. 2002. PMID: 12097889 No abstract available.
-
Efficient generation of dopaminergic neurons from mouse embryonic stem cells enclosed in hollow fibers.Biomaterials. 2006 Oct;27(28):4871-80. doi: 10.1016/j.biomaterials.2006.05.006. Epub 2006 Jun 12. Biomaterials. 2006. PMID: 16766027
-
Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.Nat Biotechnol. 1999 Jul;17(7):653-9. doi: 10.1038/10862. Nat Biotechnol. 1999. PMID: 10404157
-
Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.Curr Opin Biotechnol. 2005 Oct;16(5):487-92. doi: 10.1016/j.copbio.2005.08.005. Curr Opin Biotechnol. 2005. PMID: 16143504 Review.
-
Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.Ann N Y Acad Sci. 2005 May;1049:51-66. doi: 10.1196/annals.1334.007. Ann N Y Acad Sci. 2005. PMID: 15965107 Review.
Cited by
-
Polymer Modified Carbon Fiber-Microelectrodes and Waveform Modifications Enhance Neurotransmitter Metabolite Detection.Anal Methods. 2019 Mar 28;11(12):1620-1630. doi: 10.1039/c8ay02737d. Epub 2019 Feb 19. Anal Methods. 2019. PMID: 34079589 Free PMC article.
-
Stem cell-based approach for the treatment of Parkinson's disease.Med J Islam Repub Iran. 2015 Jan 28;29:168. eCollection 2015. Med J Islam Repub Iran. 2015. PMID: 26000262 Free PMC article. Review.
-
Rescuing macrophage normal function in spinal cord injury with embryonic stem cell conditioned media.Mol Brain. 2016 May 6;9(1):48. doi: 10.1186/s13041-016-0233-3. Mol Brain. 2016. PMID: 27153974 Free PMC article.
-
High-frequency hippocampal oscillations activated by optogenetic stimulation of transplanted human ESC-derived neurons.J Neurosci. 2012 Nov 7;32(45):15837-42. doi: 10.1523/JNEUROSCI.3735-12.2012. J Neurosci. 2012. PMID: 23136422 Free PMC article.
-
Can pluripotent/multipotent stem cells reverse Parkinson's disease progression?Front Neurosci. 2024 Jan 31;18:1210447. doi: 10.3389/fnins.2024.1210447. eCollection 2024. Front Neurosci. 2024. PMID: 38356648 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical